Proton therapy demonstrates advantages over traditional radiation therapy in Phase III head and neck cancer trial

Proton therapy demonstrates advantages over traditional radiation therapy in Phase III head and neck cancer trial retrieved 4 June 2024 from https://medicalxpress.com/news/2024-06-proton-therapy-advantages-traditional-phase.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Phase III trial shows donidalorsen cuts attack rate in hereditary angioedemaFor patients with hereditary angioedema, donidalorsen reduces the attack rate, according to a study published online May 31 in the New England Journal of Medicine to coincide with the annual congress of the European Academy of Allergy and Clinical Immunology, held from May 31 to June 3 in Valencia, Spain.
Source: medical_xpress - 🏆 101. / 51 Read more »

Experimental treatment for metastatic pancreatic cancer shows promise in phase 2 clinical trialClinicians at Georgetown University's Lombardi Comprehensive Cancer Center reported promising preliminary findings based on outcomes in the first six patients with metastatic pancreatic cancer enrolled in a phase 2 clinical trial of the experimental drug BXCL701 in combination with the immunotherapy drug pembrolizumab (Keytruda).
Source: NewsMedical - 🏆 19. / 71 Read more »

Dupilumab shows promising results in Phase 3 trial for COPD with type 2 inflammationChronic obstructive pulmonary disease patients with type 2 inflammation may soon gain access to a new drug -; dupilumab -; that showed rapid and sustained improvements in patients in a pivotal Phase 3 clinical trial, researchers report in the New England Journal of Medicine.
Source: NewsMedical - 🏆 19. / 71 Read more »

Donepezil fails to enhance cognitive abilities in breast cancer survivors: Phase III trial results To Test Whether A Dementia D...Many breast cancer survivors report cancer-related cognitive impairment following chemotherapy, although prevalence rates and severity vary.
Source: NewsMedical - 🏆 19. / 71 Read more »